Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.23.3
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Accrued liabilities:    
General and administrative $ 717 $ 855
Clinical trial related costs 2,126 1,327
Non-clinical research and manufacturing operations 411 1,779
Payroll related 38 4,828
Other accrued expenses 11 34
Total Accrued liabilities $ 3,303 $ 8,823